|Table of Contents|

cDNA cloning, lentiviral expression construction and stable HepG2 cell line establishment of Wnt Antagonist Frzb(PDF)

Chinese Journal of Applied & Environmental Biology[ISSN:1006-687X/CN:51-1482/Q]

Issue:
2014 05
Page:
775-778
Research Field:
Articles
Publishing date:

Info

Title:
cDNA cloning, lentiviral expression construction and stable HepG2 cell line establishment of Wnt Antagonist Frzb
Author(s):
MA Yuling PEI Zhe WANG Jing WEI Xiao ZENG Zhongqiu CHEN Yuwen TANG Yaxiong
Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China
Keywords:
Frzb HCC HepG2 cloning recombinant lentivirus stable cell line
CLC:
Q78 : R966
PACS:
DOI:
10.3724/SP.J.1145.2014.03045
DocumentCode:

Abstract:
Aberrant activation of the Wnt signaling pathway is closely linked to tumorigenesis in a variety of major human malignant tumors. However, the anticancer potential of Frzb/sFrp3, one of the secreted frizzled related protein (sFRP) families, in hepatocellular carcinoma is poorly understood. This research aimed to study the cDNA cloning, lentiviral expression construction and stable HepG2 cell line establishment of Wnt antagonist Frzb. The Frzb cDNA fragments were amplified by reverse transcription polymerase chain reaction (RT-PCR) from the total RNA of normal human liver HL-7702 (L02) cells, which were verified by the direct sequencing of PCR products. Secondly, the Frzb cDNA fragments were subcloned into the pLVX-IRES-ZsGreen1-Frzb or pLVX-Puro-Frzb, containing a fluorescent marker (GFP) or a puromycin resistance gene respectively; and the recombinant lentiviral expression plasmids were further confirmed by double digestion and sequencing. Thirdly, HEK293T cells were co-transfected with the lentiviral expression plasmid, plus packaging plasmid psPAX2 and envelope plasmid pMD2.G by using Lenti-X? Lentiviral Expression Systems to obtain recombinant lentiviral particles at 48 hours after transfection; then the overall titers were evaluated by fluorescence microscopy of GFP expression, and the expression of Flag-tagged Frzb successfully detected by Western blot in the infected HEK293T cells. Finally, HepG2 cells were infected with the recombinant lentiviral particles expressing Frzb and the stable Frzb-transducted HepG2 cell line was successfully established by antibiotic selection with puromycin (2 μg/mL). These findings help to lay a foundation for studies about anticancer activities and molecular mechanisms of Frzb in hepatocellular carcinoma.

References

1 Villanueva A, Hernandez-Gea V, Llovet JM. Medical therapies for hepatocellular carcinoma: a critical view of the evidence global cancer statistics [J]. Nat Rev Gastroenterol Hepatol, 2013, 10 (1): 34-42
2 Clevers H, Nusse R. Wnt/β-catenin signaling and disease [J]. Cell, 2012, 149 (6): 1192-1205
3 Cavard C, Colnot S, Audard V, Benhamouche S, Finzi L, Torre C, Grimber G, Godard C, Terris B, Perret C. Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology [J]. Future Oncol, 2008, 4 (5): 647-660
4 de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas [J]. Proc Natl Acad Sci USA, 1998, 95 (15): 8847-8851
5 Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas [J]. Oncogene, 2002, 21 (31): 4863-4871
6 Bengochea A, de Souza MM, Lefran?ois L, Le Roux E, Galy O, Chemin I, Kim M, Wands JR, Trepo C, Hainaut P, Scoazec JY, Vitvitski L, Merle P. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma [J]. Br J Cancer, 2008, 99 (1): 143-150
7 Cha MY, Kim CM, Park YM, Ryu WS. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells [J]. Hepatology, 2004, 39 (6): 1683-1693
8 Lee TH, Tai DI, Cheng CJ, Sun CS, Lin CY, Sheu MJ, Lee WP, Peng CY, Wang AH, Tsai SL. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics [J]. J Biomed Sci, 2006, 13 (1): 27-39
9 Guo Y, Xie J, Rubin E, Tang YX, Lin F, Zi X, Hoang BH. Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling [J]. Cancer Res, 2008, 68 (9): 3350-3360
10 Zi X, Guo Y, Simoneau AR, Hope C, Xie J, Holcombe RF, Hoang BH. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness [J]. Cancer Res, 2005, 65 (21): 9762-9770
11 苏鹏, 王晶, 安君霞, 朱启彧, 卢晓霞, 唐亚雄. 毛兰素对人肝癌Huh7细胞的抑制作用[J]. 应用与环境生物学报, 2011, 17 (5): 662-665 [Su P, Wang J, An JX, Zhu QY, Lu XX, Tang YX. Inhibitory effect of Erianin on hepatocellular carcinoma (HCC)Huh7 cell [J]. Chin J Appl Environ Biol, 2011, 17 (5): 662-665]
12 Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer [J]. Nat Rev Cancer, 2013, 13 (1): 11-26
13 Shi Y, He B, You L, Jablons DM. Roles of secreted frizzled-related proteins in cancer [J]. Acta Pharmacol Sin, 2007, 28 (9): 1499-1504
14 Tang Y, Simoneau AR, Liao WX, Yi G, Hope C, Liu F, Li S, Xie J, Holcombe RF, Jurnak FA, Mercola D, Hoang BH, Zi X. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells [J]. Mol Cancer Ther, 2009, 8 (2): 458-468

Memo

Memo:
-
Last Update: 2014-10-23